跳至主要内容
临床试验/NCT04006626
NCT04006626已完成不适用

18F-FES PET/CT Influences the Staging and Management of Newly Diagnosed Oestrogen Receptor-Positive Breast Cancer Patients: A Retrospective Comparative Study With 18F-FDG PET/CT

Fudan University1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2019年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
1
主要终点
Staging of breast cancer

研究概览

简要总结

To figure out whethetr 18F-FES PET/CT could influence the staging and management of newly diagnosed Oestrogen Receptor-positive Breast Cancer Patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with newly diagnosed immunohistochemical confirmed oestrogen receptor (ER)-positive breast cancer
  • Patients underwent both 18F-FES PET/CT and 18F-FDG PET/CT in Fudan University Shanghai Cancer Center within 1 week after diagnosis
  • Patients with available medical history

排除标准

  • Patients with incomplete medical history

结局指标

主要结局

Staging of breast cancer

时间窗: 6 weeks

Deliver questionnaire to phycians to investigate the staging of BC according to AJCC 8 (TNM staging).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Biyun Wang, MD

Professor

Fudan University

研究点 (1)

Loading locations...

相似试验